Other OTC - Delayed Quote • USD
Rapid Therapeutic Science Laboratories, Inc. (RTSL)
At close: April 10 at 11:09 AM EDT
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Donal R. Schmidt Jr. | President, CEO & Chairman | -- | -- | 1961 |
Mr. D. Hughes Watler Jr. | CFO & Director | 37.62k | -- | 1949 |
Dr. Duane C. Drinkwine Ph.D. | Chief Science Officer | -- | -- | -- |
Mr. Ryan C. Johnson | Vice President of Marketing | -- | -- | 1975 |
Mr. Frank Gill | Chief Isolate Laboratory Technician | -- | -- | -- |
Mr. Sean Paul Berrier | Senior Vice President | -- | -- | -- |
Rapid Therapeutic Science Laboratories, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 3
Description
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company, provides natural based relief through aerosol delivery systems for non-psychoactive cannabinoids. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas.
Corporate Governance
Rapid Therapeutic Science Laboratories, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Jan 16, 202415-12G: Notice of termination of registration of a class of securities under Section 12(g)See Full Filing
- Dec 06, 20238-K: Corporate Changes & Voting MattersSee Full Filing
- Aug 23, 20238-K: Corporate Changes & Voting MattersSee Full Filing
- Aug 14, 202310-Q: Periodic Financial ReportsSee Full Filing
- Jul 14, 20238-K: Corporate Changes & Voting MattersSee Full Filing
Upcoming Events
Upcoming Events Information Not Available